Paget's Disease of Bone: Osteoimmunology and Osteoclast Pathology

被引:15
|
作者
Rabjohns, Emily M. [1 ]
Hurst, Katlyn [2 ]
Ghosh, Arin [2 ]
Cuellar, Maria C. [3 ]
Rampersad, Rishi R. [1 ]
Tarrant, Teresa K. [1 ]
机构
[1] Duke Univ, Dept Med, Div Rheumatol & Immunol, DUMC 3874,200 Trent Dr, Durham, NC 27710 USA
[2] Duke Univ, Durham, NC USA
[3] Hosp Salvador, Div Rheumatol, Dept Med, Santiago, Chile
关键词
Paget's disease of bone; Osteoimmunology; Osteoclast; Chemokines; Chemokine receptor; Optineurin; Bisphosphonate;
D O I
10.1007/s11882-021-01001-2
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of ReviewThe purpose of this review is to recognize clinical features of Paget's disease of bone and to describe how the osteoclast, a myeloid-derived cell responsible for bone resorption, contributes to the disease.Recent FindingsRecent studies have identified several variants in SQSTM1, OPTN, and other genes that may predispose individuals to Paget's disease of bone; studies of these genes and their protein products have elucidated new roles for these proteins in bone physiology.SummaryUnderstanding the pathologic mechanisms in the Pagetic osteoclast may lead to the identification of future treatment targets for other inflammatory and autoimmune diseases characterized by abnormal bone erosion and/or osteoclast activation.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Paget’s Disease of Bone: Osteoimmunology and Osteoclast Pathology
    Emily M. Rabjohns
    Katlyn Hurst
    Arin Ghosh
    Maria C. Cuellar
    Rishi R. Rampersad
    Teresa K. Tarrant
    Current Allergy and Asthma Reports, 2021, 21
  • [2] Paget's Disease of Bone: A Disease of the Osteoclast
    Reddy S.V.
    Kurihara N.
    Menaa C.
    Roodman G.D.
    Reviews in Endocrine and Metabolic Disorders, 2001, 2 (2) : 195 - 201
  • [3] Foot pathology in patients with Paget's disease of bone
    Williams, Anita E.
    O'Neill, Terence W.
    Mercer, Sylvia
    Toro, Brigitte
    Nester, Christopher J.
    JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2006, 96 (03) : 226 - 231
  • [4] Paget's disease and osteoclast biology
    Roodman, GD
    BONE, 1996, 19 (03) : 209 - 212
  • [5] Increased nucleolar organizer regions in osteoclast nuclei of Paget's bone disease
    Chappard, D
    Retailleau-Gaborit, N
    Filmon, R
    Audran, M
    Baslé, MF
    BONE, 1998, 22 (01) : 45 - 49
  • [6] NFAM1 Stimulation of Osteoclast Differentiation in Paget's Disease of Bone
    Ethiraj, Purushoth
    Sambandam, Yuvaraj
    Reddy, Sakamuri
    Hathaway-Schrader, Jessica
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 375 - 375
  • [7] Osteoclast differentiation from circulating mononuclear precursors in Paget's disease of bone
    Neale, SD
    Smith, R
    Wass, J
    Athanasou, NA
    JOURNAL OF PATHOLOGY, 1999, 187 : 20A - 20A
  • [8] Pathology of Paget's Disease
    Sulzbacher, I.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2012, 19 (02): : 63 - 66
  • [9] Etiology of Paget's disease and osteoclast abnormalities
    Reddy, SV
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 93 (04) : 688 - 696
  • [10] Role of the Endocannabinoid/Endovanilloid System in the Modulation of Osteoclast Activity in Paget's Disease of Bone
    Paoletta, Marco
    Moretti, Antimo
    Liguori, Sara
    Di Paola, Alessandra
    Tortora, Chiara
    Argenziano, Maura
    Rossi, Francesca
    Iolascon, Giovanni
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)